insights_auto
Why is 0QF up 7,27%?
Dive Deeperchevron_right
0QF:ETR
Moderna Inc
187,76 €
arrow_upward
+7,27%(+12,72) 1D
9-окт., 17:35:58 GMT+2 · EUR
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for 0QF...
Open
175,40 €
High
193,58 €
Low
174,18 €
Mkt. cap
89,83 млд
Avg. vol.
28,88 миң
Volume
40,87 миң
52-wk high
193,58 €
52-wk low
19,37 €
No. of employees
5 миң
Open
175,40 €
High
193,58 €
Low
174,18 €
Mkt. cap
89,83 млд
Avg. vol.
28,88 миң
Volume
40,87 миң
52-wk high
193,58 €
52-wk low
19,37 €
No. of employees
5 миң
News stories
From web sources and news partners
Simply Wall Street
·
1 саат мурун
Cancer Vaccine Stocks Gaining Attention After Moderna Shares Jumped On US Backing
Stocks Down Under
·
1 саат мурун
Moderna (NASDAQ:MRNA) Stock Surges 14% as Nasdaq-100 Return and Cancer Vaccine Hopes Fuel Rally
Seeking Alpha
·
1 саат мурун
Moderna gains 14% to set fresh 52-week high (MRNA:NASDAQ)
The Globe and Mail
·
2 саат мурун
This Stock Is Up More than 560% This Year, but It Could Drop by 38%, According to Wall Street
Profile
Moderna, Inc. is an American pharmaceutical and biotechnology company based in Cambridge, Massachusetts, that focuses on RNA therapeutics, primarily mRNA vaccines. These vaccines use a copy of a molecule called messenger RNA to carry instructions for proteins to produce an immune response. The company's name is derived from the terms "modified", "RNA", and "modern".
The company's commercial products are the Moderna COVID-19 vaccine sold under the brand names Spikevax and Mnexspike, a respiratory syncytial virus vaccine sold under the brand name Mresvia, and an influenza vaccine sold under the brand name Mflusiva. The company has 44 treatment and vaccine candidates, of which 37 have entered clinical trials. Candidates include possible vaccines for influenza, HIV, Epstein–Barr virus, the Nipah virus, chikungunya, human metapneumovirus, varicella zoster virus, as well as a cytomegalovirus vaccine, a Zika virus vaccine funded by the Biomedical Advanced Research and Development Authority, and three cancer vaccines.
In May 2026, Time ranked Moderna first in their list of the World's Most Impactful Companies. Wikipedia
About Moderna Inc